77 related articles for article (PubMed ID: 7894109)
21. Basal cell carcinoma of the skin: a biologic marker for visceral malignancy.
Debrowsky R; Hukill PB; Lundy JL
Conn Med; 1978 Jan; 42(1):8-10. PubMed ID: 620537
[No Abstract] [Full Text] [Related]
22. [Immunohistochemical observation of infiltrated lymphocytes in squamous cell carcinoma].
Sai Y; Ohashi M; Nagura H
Nihon Hifuka Gakkai Zasshi; 1987 Sep; 97(10):1117-28. PubMed ID: 3326950
[No Abstract] [Full Text] [Related]
23. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy.
Urosevic M; Kempf W; Zagrodnik B; Panizzon R; Burg G; Dummer R
Clin Exp Dermatol; 2005 Jul; 30(4):422-5. PubMed ID: 15953086
[TBL] [Abstract][Full Text] [Related]
24. Skin site mast cell numbers correlate with rates of nodular growth, but not incidence, of basal cell carcinoma.
Weber A; Maurer M
Dermatology; 2005; 211(3):298-9. PubMed ID: 16205081
[No Abstract] [Full Text] [Related]
25. [Immuno-allergological studies in skin cancer].
Michailow P; Berowa N; Kutintschev M
Hautarzt; 1966 Aug; 17(8):356-7. PubMed ID: 4965047
[No Abstract] [Full Text] [Related]
26. T lymphocytes with Fc-IgG receptors in skin cancers.
Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
Acta Derm Venereol; 1981; 61(6):555-8. PubMed ID: 6177170
[No Abstract] [Full Text] [Related]
27. Cell-mediated immune response to basal cell carcinoma.
Raffle EJ; MacLeod TM; Hutchinson F
Acta Derm Venereol; 1981; 61(1):66-8. PubMed ID: 6164220
[TBL] [Abstract][Full Text] [Related]
28. [The immunological characteristics of metatypic skin cancer].
Snarskaia ES
Sov Med; 1991; (7):90. PubMed ID: 1948364
[No Abstract] [Full Text] [Related]
29. Decreased lymphocyte blastogenic responses in patients with multiple basal cell carcinoma.
Myskowski PL; Safai B; Good RA
J Am Acad Dermatol; 1981 Jun; 4(6):711-4. PubMed ID: 7240477
[No Abstract] [Full Text] [Related]
30. Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.
Otsuka A; Dreier J; Cheng PF; Nägeli M; Lehmann H; Felderer L; Frew IJ; Matsushita S; Levesque MP; Dummer R
Clin Cancer Res; 2015 Mar; 21(6):1289-97. PubMed ID: 25593302
[TBL] [Abstract][Full Text] [Related]
31. [An immunohistochemical study on basal cell epithelioma using anti-keratin monoclonal antibodies].
Shimizu N
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):691-7. PubMed ID: 2442439
[No Abstract] [Full Text] [Related]
32. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
33. The incidence of skin cancer is growing rapidly.
Nouri K
Int J Dermatol; 2004 Aug; 43(8):622. PubMed ID: 15304193
[No Abstract] [Full Text] [Related]
34. HLA linkage of warts and basal cell carcinomas in renal transplant recipients.
Welsh KI; Higgins E; Tidman M; Cameron JS; Koffman CG; Ogg CS; Williams DG
Transplant Proc; 1989 Feb; 21(1 Pt 1):579. PubMed ID: 2495620
[No Abstract] [Full Text] [Related]
35. The immunology of basal cell carcinoma.
Myskowski PL; Safai B
Int J Dermatol; 1988 Nov; 27(9):601-7. PubMed ID: 3068167
[No Abstract] [Full Text] [Related]
36. [Suppression of gamma-interferon induced HLA-DR antigen expression on normal and transformed keratinocytes by 1,25 (OH)2 vitamin D3].
Tone T; Eto H; Katsuoka K; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):519-25. PubMed ID: 1909764
[TBL] [Abstract][Full Text] [Related]
37. Indomethacin in basal cell carcinoma.
al-Waili NS
J Pak Med Assoc; 1989 May; 39(5):134-6. PubMed ID: 2504951
[No Abstract] [Full Text] [Related]
38. DNCB reactivity in patients with skin carcinoma.
Bleumink E; Nater JP
Dermatologica; 1974; 148(1):44-6. PubMed ID: 4364858
[No Abstract] [Full Text] [Related]
39. Melanoma and nonmelanoma skin cancers and the immune system.
Domingo DS; Baron ED
Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
[No Abstract] [Full Text] [Related]
40. Failure to detect circulating IgG or IgM antibodies to basal cell carcinoma by immunofluorescence.
Blewitt RW; Aparicio SR; Burrow HM; Rowell NR; Rowell RM
Acta Derm Venereol; 1978; 58(1):82-3. PubMed ID: 75642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
